# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-094007
Filing Date
2024-08-08
Accepted
2024-08-08 16:15:39
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | vtyx-20240630.htm iXBRL | 10-Q | 2556599
2 | EX-10.2 | vtyx-ex10_2.htm | EX-10.2 | 41574
3 | EX-31.1 | vtyx-ex31_1.htm | EX-31.1 | 17205
4 | EX-31.2 | vtyx-ex31_2.htm | EX-31.2 | 17224
5 | EX-32.1 | vtyx-ex32_1.htm | EX-32.1 | 9906
6 | EX-32.2 | vtyx-ex32_2.htm | EX-32.2 | 9929
| Complete submission text file | 0000950170-24-094007.txt |  | 9388317

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | vtyx-20240630.xsd | EX-101.SCH | 1117330
72 | EXTRACTED XBRL INSTANCE DOCUMENT | vtyx-20240630_htm.xml | XML | 1724551

Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40928 | Film No.: 241188572
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)